Arda Therapeutics is a seed-stage biotech based in the San Francisco Bay Area, aiming to treat chronic diseases and ageing by eliminating the pathological cells that drive these conditions. The company uses single-cell data from patients to identify pathological cells and specific markers to target them. 

Arda is focusing on treating chronic diseases, with the long-term goal of extending healthy lifespan.

The company is backed by Andreessen Horowitz, GV, The Longevity Fund, Village Global, Axial, NJF and others.